{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15516722", "DateCompleted": {"Year": "2005", "Month": "04", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0918-6158", "JournalIssue": {"Volume": "27", "Issue": "11", "PubDate": {"Year": "2004", "Month": "Nov"}}, "Title": "Biological & pharmaceutical bulletin", "ISOAbbreviation": "Biol Pharm Bull"}, "ArticleTitle": "Effects of morin on blood pressure and metabolic changes in fructose-induced hypertensive rats.", "Pagination": {"StartPage": "1779", "EndPage": "1783", "MedlinePgn": "1779-83"}, "Abstract": {"AbstractText": ["High fructose (HF) feeding induces a moderate increase in blood pressure in rats, which is associated with insulin resistance, hyperinsulinemia, and hypertriglyceridemia. In the present study, we examined the chronic effect of morin, a flavonoid isolated from medicinal plants, on blood pressure, lipid profiles, and serum insulin and glucose in HF-induced hypertensive rats. Rats were divided into control group and HF-fed group during the first three weeks of experiments. Then, rats were further divided into four groups and treated for 4 more weeks as follows: 1) control group; 2) morin-treated (intraperitoneal 5 mg/kg/d) control group; 3) HF-fed group; 4) morin-treated, HF-fed group (n=8, each group). Morin-treated HF-fed group showed lower systolic blood pressure (SBP) (132.0+/-2.5 mmHg vs. 142.8+/-2.2 mmHg, p<0.05), lower serum insulin level (1.21+/-0.27 vs. 2.73+/-0.30 microIU/dl, p<0.05), and lower plasma triglycerides (47.8+/-5.0 vs. 65.5+/-5.0 mg/dl, p<0.05) than those of HF-fed group. Morin treatment also suppressed mRNA expression of endothelin-1 (ET-1) in the thoracic aorta from HF-induced hypertensive rats. Moreover, decreased renal sodium excretion in HF-induced hypertensive rats was ameliorated by morin treatment. In conclusion, the results of this study demonstrate that morin has an anti-hypertensive effect in HF-induced hypertensive rats. This effect of morin may be associated with the suppression of serum insulin and plasma triglyceride level, with the down-regulation of ET-1 in the thoracic aorta, and with the partial amelioration of renal dysfunctions in HF-induced hypertensive rats."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Herbal Resources, Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk, Republic of Korea."}], "Identifier": [], "LastName": "Kang", "ForeName": "Dae Gill", "Initials": "DG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Moon", "ForeName": "Mi Kyoung", "Initials": "MK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sohn", "ForeName": "Eun Jin", "Initials": "EJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Dae Ho", "Initials": "DH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lee", "ForeName": "Ho Sub", "Initials": "HS"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Biol Pharm Bull", "NlmUniqueID": "9311984", "ISSNLinking": "0918-6158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Endothelin-1"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Triglycerides"}, {"RegistryNumber": "30237-26-4", "NameOfSubstance": "Fructose"}, {"RegistryNumber": "8NFQ3F76WR", "NameOfSubstance": "morin"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Aorta"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["blood"], "DescriptorName": "Cholesterol"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Endothelin-1"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Fructose"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": ["blood"], "DescriptorName": "Insulin"}, {"QualifierName": ["drug effects", "physiopathology"], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["blood"], "DescriptorName": "Triglycerides"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "11", "Day": "2", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "4", "Day": "20", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "11", "Day": "2", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15516722", "10.1248/bpb.27.1779", "JST.JSTAGE/bpb/27.1779"]}}], "PubmedBookArticle": []}